Metraipolis › archive › dc_2b469711b020
Modeling brain metastases in cost effectiveness analysis of atezolizumab for extensive stage small cell lung cancer — Europe PMC PMID:41214083
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41214083
- DOI
- 10.1038/s41598-[numero omesso]-4
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T16:54:04.859Z
- SHA-256 of the archived text
73acfc25273cff31455b98fadbed32bc8310ba11063fd3a2bf2b5baa6e3f77d8- Stable URL of this page
https://metraipolis.com/documento/dc_2b469711b020
How to cite
Modeling brain metastases in cost effectiveness analysis of atezolizumab for extensive stage small cell lung cancer — Europe PMC PMID:41214083 — Europe PMC (en), https://europepmc.org/article/MED/41214083 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2b469711b020 (Metraipolis archive dc_2b469711b020, sha256 73acfc25273cff31455b98fadbed32bc8310ba11063fd3a2bf2b5baa6e3f77d8)
BibTeX
@misc{dc2b469711b020,
title = {Modeling brain metastases in cost effectiveness analysis of atezolizumab for extensive stage small cell lung cancer — Europe PMC PMID:41214083},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41214083},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2b469711b020; sha256 73acfc25273cff31455b98fadbed32bc8310ba11063fd3a2bf2b5baa6e3f77d8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41214083. Agents can read the archived copy with the MCP tool read_document.